Litigation

Recent Posts

Another Specialty Pharmacy Settles Exjade False Claims Allegations For $45 Million
Posted on 1 May 2015 by Tom Moylan

NEW YORK —(Mealey’s) Specialty pharmacy Accredo Health Group Inc. on April 30 agreed to pay $45 million to settle a whistle-blower’s allegations that its efforts to push prescriptions for the iron chelation drug Exjade resulted in false... Read More

$12.8M Verdict For Jaw Injury In Aredia/Zometa Case To Be Reduced To $1.14M
Posted on 24 Nov 2010 by Tom Moylan

WINSTON-SALEM, N.C. - (Mealey's) A North Carolina federal jury on Nov. 22 awarded $12,887,001 in an Aredia/Zometa jaw injury case, a verdict that will be reduced to $1,148,001 by North Carolina's limit on punitive damages ( Herbert Fussman, et... Read More

Jury Awards Plaintiff $10.4 Million For Injuries, Punitive Damages Linked To Novartis' Zometa
Posted on 5 Nov 2012 by Tom Moylan

CENTRAL ISLIP, N.Y. - (Mealey's) A New York federal jury on Nov. 2 found Novartis Pharmaceuticals Corp. liable for a woman's osteonecrosis of the jaw (ONJ) and awarded her $10.45 million, according to the parties ( Barbara Davids v. Novartis Pharmaceuticals... Read More

Novartis Wins Defense Verdict In Zometa Jaw Injury Trial
Posted on 26 May 2011 by Tom Moylan

BROOKLYN, N.Y. (Mealey's) A New York federal jury in the first federal Zometa trial found May 25 that the plaintiff did not prove by a preponderance of evidence that the Novartis Pharmaceuticals Corp. drug caused a decedent's osteonecrosis of... Read More

Novartis To Pay $422.5M In Marketing, Kickbacks Case
Posted on 1 Oct 2010 by LexisNexis Litigation Resource Community Staff

PHILADELPHIA - (AP) Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, federal officials announced Thursday... Read More

Novartis Hit With $250M Punitive Damage Award
Posted on 19 May 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) A jury that found drug company Novartis discriminated against women by paying them less than men, promoting fewer of them and allowing a hostile workplace awarded $250 million in punitive damages on Wednesday. The same jury concluded... Read More

NYC Jury: Novartis Discriminated Against Women
Posted on 17 May 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) A jury has decided that the drug company Novartis AG engaged in a pattern of discrimination against women, paying them less than men and treating pregnant women unfavorably. The verdict was returned Monday in Manhattan federal court... Read More